Attenuation of acute and chronic liver injury in rats by iron-deficient diet
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Oxidative stress due to iron deposition in hepatocytes or Kupffer cells contributes to the initiation and perpetuation of liver injury. The aim of this study was to clarify the association between dietary iron and liver injuries in rats. Liver injury was initiated by the administration of thioacetamide or ligation of the common bile duct in rats fed a control diet (CD) or iron-deficient diet (ID). In the acute liver injury model induced by thioacetamide, serum levels of aspartate aminotransferase and alanine aminotransferase, as well as hepatic levels of lipid peroxide and 4-hydroxynonenal, were significantly decreased in the ID group. The expression of 8-hydroxydeoxyguanosine and terminal deoxynucleotidyl transferase biotin-dUTP nick-end labeling positivity showed a similar tendency. The expression of interleukin-1β and monocyte chemotactic protein-1 mRNA was suppressed in the ID group. In liver fibrosis induced by an 8-wk thioacetamide administration, ID suppressed collagen deposition and smooth muscle α-actin expression. The expressions of collagen 1A2, transforming growth factor β, and platelet-derived growth factor receptor β mRNA were all significantly decreased in the ID group. Liver fibrosis was additionally suppressed in the bile-duct ligation model by ID. In culture experiments, deferoxamine attenuated the activation process of rat hepatic stellate cells, a dominant producer of collagen in the liver. In conclusion, reduced dietary iron is considered to be beneficial in improving acute and chronic liver injuries by reducing oxidative stress. The results obtained in this study support the clinical usefulness of an iron-reduced diet for the improvement of liver disorders induced by chronic hepatitis C and alcoholic/nonalcoholic steatohepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070 · cited 3×
“However, the presence of free iron and deposition of iron in cells often occurs under some pathological conditions, triggering oxidative stress and inflammation (4, 24, 30).”
BackgroundHereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992 · cited 2×
“long been studied in fields of hemochromatosis (2, 31) and”
BackgroundChemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308 · cited 1×
“In particular, the clinical use of ICL670 (deferasirox), an orally administrable Fe(3) -chelator, in hepatic iron overload is now awaited (14, 16).”
BackgroundHepatotoxicity of Iron Overload: Mechanisms of Iron-Induced Hepatic Fibrogenesis
Ramm, G. A., & Ruddell, R. G. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923315 · Cited by 221
Cited by
Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target
Dongiovanni, P., Fracanzani, A. L., Fargion, S., & Valenti, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.008 · Cited by 362
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…2007; Kaito et al. 2006; Kato et al. 2001, 2007; Ko et al. 2007; Mahmoud et al. 2008; Mueller et al. 2006; Nahon et al. 2008; Nishina et al. 2008; Otogawa et al. 2008; Price and Kowdley 2009; Rigamonti et al. 2005; Sebastiani and Walker 2007; Sikorska et al. 2010; Sugimoto et al. 2009; Tanaka…”
BackgroundIron in arterial plaque: A modifiable risk factor for atherosclerosis
Sullivan, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.005 · Cited by 176
Pathophysiology of NASH: perspectives for a targeted treatment
Marra, F., & Lotersztajn, S. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990344 · Cited by 163
Iron deficiency impairs Intra-hepatic lymphocyte mediated immune response
Bonaccorsi-Riani, E., Danger, R., Lozano, J. J., Martinez-Picola, M., Kodela, E., Mas-Malavila, R., Bruguera, M., Collins, H. L., Hider, R. C., Martinez-Llordella, M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136106 · Cited by 57
Metadata
- Authors
- Otogawa, K., Ogawa, T., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., & Kawada, N.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2008-02
- Volume
- 294
- Issue
- 2
- Pages
- R311-R320
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2167449023
- Cited by
- 31
- References
- 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attenuation of acute and chronic liver injury in rats by iron-deficient diet. https://app.cochat.ai/papers/10.1152/ajpregu.00735.2007
- The paper
- Otogawa, K., Ogawa, T., Shiga, R., Nakatani, K., Ikeda, K., Nakajima, Y., & Kawada, N. (2008). Attenuation of acute and chronic liver injury in rats by iron-deficient diet. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. https://doi.org/10.1152/ajpregu.00735.2007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.